Patients with fibromyalgia have a substance P level three times higher than healthy subjects; substance P modulates the intervention of the N-methyl-d-aspartate receptor (NMDAR) at the thalamic level, stimulating thalamic mast cells [15,21]. This evidence concerns the gene TAC1 and fibromyalgia.